Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
FDMT logo

FDMT

NGS
4D Molecular Therapeutics Inc.
ManufacturingBiological Product (except Diagnostic) Manufacturing
Watchlists:
Last updated: Tuesday 15th July 2025
4.22
-0.14 (-3.20%)
Prev Close:4.38
Open:4.4
Bid:4.21
Ask:4.24
52 Week Range
2.24
28.93
Volume:437,838
Mkt Cap:195 M
Price Target
$4.85
+14.9%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

FDMT - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Invalid date
Depreciation And Amortization5 M4 M2 M2 M1 M
General And Administrative Expense47 M36 M33 M28 M17 M
Gross Profit Margin (profit Margin After CGS)37000.021 M3 M18 M14 M
Misc Other Special Charges-77000.0-181000.0-35000.0-121000.0-181000.0
Net Income (loss)-161 M-101 M-107 M-71 M-57 M
Net Income Common Stockholders-161 M-101 M-107 M-71 M-57 M
Net Income Continuous Operations-161 M-101 M-107 M-71 M-57 M
Net Non Operating Interest Income Expense27 M12 M3 M137000.0152000.0
Normalized Income-159 M
Operating Income-188 M-113 M-110 M-71 M-57 M
Operating Income Before Depreciation (EBITDA)-154 M-95 M-106 M-68 M-55 M
Operating Expense188 M134 M113 M89 M70 M
Other Gand A47 M36 M33 M28 M17 M
Other Operating Expenses-3 M-4 M-3 M-2 M-2 M
Research Expense141 M97 M80 M61 M53 M
Salaries And Wages26 M20 M
Total Income Available For Interest Expense (EBIT)-161 M-101 M-110 M-71 M-57 M
Total Revenues37000.021 M3 M18 M14 M
Total Expenses188 M134 M113 M89 M70 M
Total Revenue37000.021 M3 M18 M14 M
Avgshs54 M39 M32 M28 M6 M
Avgshsdt54 M39 M32 M6 M
Basiceps-2.98-2.58-3.32-2.57-8.82
Basicepscont-2.98-2.58-3.32-2.57-8.82
Depamor5 M4 M2 M2 M1 M
Dileps-2.98-2.58-3.32-2.57-8.82
Dilepscont-2.98-2.58-3.32
Intinc27 M12 M3 M137000.0152000.0
Netincdisc-161 M-101 M-107 M-71 M-57 M
Othincexp77000.0181000.0-35000.0121000.0181000.0
Pretaxinc-161 M-101 M-107 M-71 M-57 M
Resdev141 M97 M80 M61 M53 M
Sga47 M36 M33 M28 M17 M
Shsout56 M50 M33 M32 M27 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader